Explore
Iterate
Vision
Log in
Sign up
AAVogen
Join to edit
Expert in commercialization and manufacturing of AAV-based gene therapeutics. 28 years pharma experience and senior leadership (e.g. CEO, Sr. VP) at Shire, AstraZeneca, GSK and Ambrx.
Tom Lloyd
Advisor
Denis Guttridge
Charles Murry
Jeff Chamberlain
Paul Gregorevic
6 members
Current role
Lawson Macartney
Brad Handler
Advisor at Bryte
Stuart Mitchell
Nick Telson
Advisor at CINCHONA
Jonathan C. Javitt
Advisor at Trice Imaging
Ariane Cornell
Advisor at Secure World Foundation
Bruno Sánchez-Andrade Nuño